Highlights
• The World Health Organization (WHO) has downplayed effectiveness of remdesivir by saying it has been appeared that the drug has little or no effect on hospitalised coronavirus patients
• According to the NIAD study’s data, the remdesivir treatment protocol may have curbed the progression of a more severe respiratory disease
• The results published in the New England Journal of Med....
Tags : Remdesivir, Gilead Sciences, COVID-19, NIAD, WHO,
comments (0)